This work focuses on the analysis of genotoxic effects on human peripheral lymphocytes exposed in vitro to different arsenic (As) compounds by means of the cytokinesis-block micronucleus assay. The study was carried out by challenging peripheral human lymphocytes with six As compounds in trivalent or pentavalent forms such as arsenite (As III ) and arsenate (As V ) and organoarsenic species such as monomethylarsonous acid (MMAs III ), monomethylarsonic acid (MMAs V ), dimethylarsinic acid (DMAs V ) and trymethylarsine oxide (TMAO V ). For As III and As V at concentrations of 4 and 32 mM, respectively, an increase of micronuclei (MN) frequency was found. MMAs III and MMAs V induced a statistically significant increase of MN frequency at the dose of 2 and 500 mM, respectively. For DMAs V , no significant increase of MN was observed, although a decrease of the nuclear division index (NDI) was evident, indicating a cytotoxic effect. The genotoxic mechanism of action of MMAs III was further evaluated by means of fluorescence in situ hybridization analysis. Due to a higher percentage of centromere-positive MN, MMAs III showed a clear aneuploidogenic property. Finally, for TMAO V no genotoxicity was observed up to 1 mM. These results show how speciation is important in determining the genotoxic and cytotoxic effects of As compounds in human peripheral lymphocytes and support the emerging hypothesis that the induction of aneuploidy could be a mechanism by which As exerts its carcinogenic properties.
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Introduction
Significant exposure to arsenic (As) occurs through both anthropogenic and natural sources. Occupational exposure to arsenic is common in the smelting industry as by-products of ores containing lead, zinc and nickel and is increasing in the microelectronics industry. Populations are exposed also through the commercial use of arsenic compounds in products such as pesticides, herbicides and paints, and through the burning of fossil fuels. The human exposure to As-contaminated water can induce the onset and progression of pathologies like anaemia, neuropathies, hyperpigmentation, skin irritation and lung, dermal and bladder cancer. For this last reason, As is now considered by International Agency for Research on Cancer to be a Class I carcinogen (1) . As a consequence of these toxic effects on human health, many countries have adopted standard rules to limit the amount of arsenic in drinking water, leading the United States National Research Council to recommend to the Environmental Protection Agency the value of 10 lg/litre of As. Moreover, industrial pollution can contribute to the increase of As in the environment, so that inorganic arsenic is still nowadays considered of primary importance by both toxicologists and ecotoxicologists (2, 3) .
Following ingestion, inorganic arsenic, both in the trivalent and in the pentavalent form, is metabolized by successive oxidation, methylation and reduction steps leading to organoarsenic metabolites. Cullen and Remer (4) described the biomethylation of arsenic as follows:
In mammalian cells, arsenic methylation was suggested to be an enzymatic process involving the action of specific arsenic methyltransferases to add a methyl group to form monomethylated (MMAs) and then dimethylated (DMAs) species either in pentavalent (MMAs V , DMAs V ) or in trivalent (MMAs III , DMAs III ) chemical form (5) . However, recent findings by Hayakawa et al. (6) suggest that these methylation processes are not direct mechanisms (e.g. As III / MMAs III ), but rather they are activated via the formation of glutathione (GSH) complexes (arsenic triglutathione or monomethylarsonic diglutathione) by Cyt19 arsenic methyltransferase. A fraction of As in the body can be eliminated in urine, whereas the rest can be trapped mainly in tissues rich in sulfhydryl groups like derma, hairs and nails (7) . The primary metabolic compound found in urine, and usually used as a biomarker of exposure, is DMAs V . Latest data reveal that also another metabolite, trimethylarsine oxide (TMAO V ), can be found, in minimal quantity, in urine (5) but it is not yet known if the presence of this compound is due to a methylation mechanism or is triggered by the accumulation through the diet (e.g. some types of fish and crustaceans) of arsenic in an organic form (8) .
Arsenic genotoxicity has been analysed extensively in a wide range of in vivo (9-12) and in vitro (5,13-15) studies and the overall conclusion is that there is a clear induction of genotoxic effects, including an increase in micronucleus (MN) frequency and a decrease in the proliferation index that reflects its toxic potential. Nesnow et al. (16) (18) . Authors also tested the mutagenicity of arsenicals in mouse lymphoma cells, in Salmonella and by prophage induction in Escherichia coli, concluding that the trivalent methylated arsenicals were powerful clastogens and DNAdamaging agents, but not point mutagens or SCE inducers; moreover, they observed that several of the arsenicals were also spindle poisons, suggesting a role for these forms in inducing aneuploidy (18) . Recent findings on the molecular mechanisms associated to toxic effects of As have revealed that, also if in different way, it is able to interfere with oxidative stress, diminishing DNA repair capacity, altering DNA methylation patterns, cell proliferation and apoptosis (5) . Concerning arsenic genotoxicity, two different mechanisms have been proposed: the interference with the DNA repair processes and the induction of oxidative stress. According to the first mechanism, trivalent As would produce DNA damage by the inhibition of the repair enzymes (19) . It seems in fact that As can inhibit the excision phase of DNA repair processes at a concentration of $2.5 lM (19). Moreover, arsenate inhibits the DNA ligase through the inactivation of the essential thiolic groups (19) . The second mechanism, that could justify the As genotoxicity, seems to be due to its capacity to activate the reactive oxygen species in the redox reactions (20) . More recently, Kligerman et al. (21) investigated the spindle inhibitory properties of six arsenicals on human lymphoblasts. In their study, these authors observed that the trivalent methylated arsenicals are the more potent aneuploidy-inducing forms of arsenic, whereas none of the tested pentavalent arsenicals gave significant results. Moreover, MMA III was the most potent of the arsenicals tested (21). In conclusion, the authors showed that trivalent methylated arsenicals not only possess DNA-damaging and clastogenic capabilities (17, 18) but are also able to induce aneuploidy (21) .
The aim of this study was to evaluate the genotoxic effects of inorganic and organic arsenic compounds in human peripheral lymphocytes by the MN test in order to better characterize the genotoxicity related to the chemical characteristics of the substances. Moreover, to better discriminate between the clastogenic and aneuploidogenic properties of MMAs III , we evaluated the presence of positive (Cþ MN) or negative (CÀ MN) MN by applying the fluorescence in situ hybridization (FISH) technique with an All Human Centromere Probe.
Materials and methods

Chemicals
The following compounds were tested: sodium arsenite À2 or 10 À3 M. Aliquots of the concentrated solutions were added to culture medium (not exceeding 1% v/v) in order to obtain the final concentrations to be tested in the experiments. Then, the resulting solutions were equilibrated for 2 h at 25°C before incubation with cells. Under these conditions, compounds were stable and no transformation or change of the oxidation state occurred as determined by high performance liquid chromatography (HPLC) inductively coupled plasma mass spectrometry (ICP-MS). Mitomycin C was used as a positive clastogenic control at the concentration of 170 ng/ml in sterile distilled water. Griseofulvin was used as an aneuploidogenic control at the concentration of 43 lM. Before the treatment, the solutions were sterile filtered using a 0.2-lm mini-filter (Minisart, Sartorius, Italy).
Donors and blood collection
To assess the genotoxic effects of As compounds, the study was performed on human peripheral lymphocytes of three healthy male volunteers. All subjects were informed of the scope of the study and gave their written consent that was submitted and approved by the local Ethics Committee. Approximately 4-6 ml of blood was drawn by venipuncture in Li-heparin vials (Emoplast, Vacutest, Lot No. 1734) according to standard procedure. The donors were chosen according to the following criteria: young age (their mean age was 31.66 AE 2.51 years), non-smokers, without pharmacological treatments for at least 3 weeks before donation and without any radiological examination performed within the previous 3 months. Donors were excluded from the study if any chronic illness, genetic or oxidative stress-related pathologies, such as obesity, diabetes mellitus or cancer, were reported in the pedigree (22) .
Cytokinesis-block micronucleus assay
The cytokinesis-block micronucleus (CBMN) assay was performed according to the procedure described by Migliore et al. (23) . Briefly, blood was drawn from the volunteers and whole blood was used to prepare two paired independent lymphocyte cultures for each subject. Standard medium was prepared with RPMI 1640 (Gibco BRL, Italy) supplemented with 10% foetal bovine serum (Gibco BRL), 1.5% phytohaemagglutinin (Gibco BRL) and 1% penicillin-streptomycin (Gibco BRL). After 24 h, the cells were exposed to concentrations of As compounds ranging from 0.5 to 4 lM for As III , 4 to 32 lM for As V , 0.01 to 2 lM for MMAs III , 50 to 1000 lM for MMAs V , 50 to 250 lM for DMAs V and 100 to 1000 lM for TMAO V . Cytochalasin B (6 lg/ml) was added at 44 h to block the cytokinesis process, and lymphocyte cultures were harvested after 72 h (24) . Cells were then treated with an hypotonic solution (0.075 M KCl) to lyse erythrocytes for 3 min, prefixed in 3:5 methanol:acetic acid, washed once with methanol and subsequently fixed twice with a 7:1 methanol:acetic acid fixative solution. Finally, the cell solution was dropped onto cold glass slides. The staining procedure was performed by immersing the air-dried slides in a 2% Giemsa solution. Two thousand binucleated cells for each experimental point were examined blindly, following the scoring criteria adopted by the HUman MicroNucleus Project (25) . We evaluated the binucleated micronucleated lymphocytes (BNMN) frequency as the number of binucleated lymphocytes containing one or more MN per 1000 binucleated cells. Moreover, 500 lymphocytes were scored to evaluate the percentage of binucleated cells and the nuclear division index (NDI) was calculated according to the following formula:
where MONO, BN, TRI and TETRA are mononuclear, binucleated, trinucleated and tetranucleated lymphocytes, respectively.
Fluorescence in situ hybridization
Slides for FISH analysis were prepared as described in the previous paragraph until the fixation procedure. In fact, slides for FISH analysis were prepared by using a 3:1 ratio of methanol:acetic acid fixative solution. After the fixing procedure, the slides were allowed to dry for at least 1 h. Slides for probing were pre-treated by an incubation period of 30 min at 37°C in 2Â standard saline citrate (SSC), pH 7.0 (Sigma Aldrich, Italy), with 0.5% of Igepal (Sigma Aldrich) followed by a 70, 80 and 95% ethanol dehydration steps for 2 min. Probe and slides denaturation was performed as follows: All Human Centromere probe (Cat. No. PAHC0001-R, Resnova, Italy) was denaturated for 5 min at 95°C and placed on ice until use. Slides were instead denatured for 2 min in 70% formamide, 2Â SSC. Slides were then dehydrated as already described above. The hybridization procedure was obtained by placing the slides with $15 ll of probe, covered with a coverslip, overnight at 37°C in a humidified chamber (50% formamide, 2Â SSC). The post-hybridization washing steps were performed as follows: 5 min at 65°C in 1Â washing buffer (0.5Â SSC, 0.1% sodium dodecyl sulphate) and 5 min in 1Â washing buffer (4Â SSC, 0.1% Tween 20) at room temperature. Finally, the slides were dehydrated in 70, 80 and 95% ethanol for 2 min. To visualize the fluorescence, the slides were counterstained by applying 25 ll of 4#,6-diamidino-2-phenylindole/antifade (0.
Statistical analyses
Statistical analyses, where reported, were performed by the general linear model (GLM) and the differences were considered statistically significant at P ,0.05 when the evaluation of the treatment was analysed. For each donor, the increase in the BNMN frequency was evaluated and tested for statistical significance using Fisher's exact test.
Results
For all the As compounds tested (As , the dose range used was derived from preliminary experiments in which it was possible to observe the concentration range where the substances were exerting their toxic effects (data not shown). When compounds with cytotoxic activity have been used, the highest analysed concentration chosen was that with a reduction of cell viability (evaluated by means of the NDI) of $50%.
Results obtained with the MN test for all the donors exposed to inorganic trivalent As demonstrated a statistically significant increase in the frequency of BNMN (&) as analysed by GLM (Table 1) . When the effect of the treatment was considered for each donor, the statistical significance, performed by the Fisher's exact test, was homogenous in the group, starting from the concentration of 2 lM (P , 0.01). In order to better characterize the effects of As III , the NDI was also evaluated (Table 1) . After exposure to inorganic pentavalent As, the analysis of BNMN & shows, starting from 16 lM, concentrationdependent increases (Table 2) in MN in lymphocytes. The mean of the BNMN & donor considered indicates that statistical significance (P , 0.05) was reached at the two highest doses tested (16 and 32 lM) . The treatment with this compound for each donor shows a statistically significant increase at 16 and 32 lM (P , 0.01 and P , 0.001) for two donors and at 8, 16 and 32 lM (P , 0.01 and P , 0.001) for the third.
The analysis of BNMN frequency after exposure of lymphocytes to MMAs III at concentrations ranging from 0.01 to 2 lM is presented in Table 3 . This As compound induces (Figure 1 ). In the FISH experiment, As III , as an inorganic control, was also analysed. The results demonstrate that the genotoxic effect of this compound can be considered both clastogenic and aneuploidogenic ($50% of Cþ and CÀ) (Figure 1) .
Concerning the exposure of lymphocytes to MMAs V (Table  4 ) (concentrations tested from 50 lM to 1 mM), the genotoxic effect was higher if compared with those of the previous tested compounds. The concentration-dependent increase of the BNMN & was observed starting from 100 lM ( Table 4) . Although some values are missing for donors 2 and 3 (Table 4 ) and the first statistically significant values are highly variable, 100 lM for donor 1 and 3 and 500 lM for donor 2, the final appearance of the data indicates clear genotoxic effects. Tables 5 and 6 report the corresponding data related to the exposure of lymphocytes to DMAs V and TMAO V . Although an increased toxicity is demonstrated for DMAs V (Table 5 ) by the clear decrease in the NDI (Table 5 ) for all the donors analysed, no statistical significance in the BNMN frequency was observed, apart from donor 2 (P , 0.05) at 250 lM DMAs V . TMAO V , tested in a range of concentrations from 100 to 1000 lM (Table 6) , did not show any mutagenic activity.
Discussion
In this study, the genotoxic effects induced by two inorganic (trivalent and pentavalent) chemical compounds of (26, 18) . Like our data, Kligerman et al. (18) were able to show that methylated trivalent species, as well as some of the other species, are able to induce genotoxic effects in human lymphocytes analysed by means of CA, SCE, aberrant cells, replicative index and mitotic index (18) . Considering the genotoxic capacity of As compounds, our data, compared to those of Kligerman et al. (18) , focus the attention on a specific toxic biomarker like MN by analysing the modulation of the frequency of binucleated micronucleated human peripheral lymphocytes. This latter biomarker is of fundamental importance to better understand the molecular mechanisms involved in the toxic effects since it is able to show also the real interference with the mitotic apparatus. Numerous studies, in fact, have demonstrated that these As compounds can immediately interact with DNA causing CA, SCE and MN in many cell systems. Sodium arsenite, starting from a concentration of 0.5 lM, has been shown to cause a significant induction of MN in human lymphocytes in vitro (27) . Moreover, a significant induction of CA, SCE and MN in chinese hamster overy (CHO) cells from 10 lM was observed (28) . Despite this wide range of data, genotoxicity studies on human peripheral lymphocytes are rare. In order to verify the genotoxic effects of different arsenic compounds, we have used the CBMN assay (24) on human peripheral lymphocytes. This simple, sensible and reproducible methodology represents a valid screening system to investigate the genotoxic capacity of chemicals. Arsenic compounds have been analysed in lymphocytes from a population of three male non-smokers and healthy donors, with a mean age of $32 years old. In fact, many studies have demonstrated that the MN frequency is an endpoint highly variable due to factors such as gender, females show a higher MN frequency than the one observed in males (29, 30) , and age, in both sexes the frequency has been demonstrated to be considerably higher in individuals .40 years of age (29, 31) . We used different donors to take into account the possible interindividual variability in the treatment with different compounds, since genotypic variations regarding the arsenic metabolism could interfere with the susceptibility to the toxic, genotoxic and possibly carcinogenic effects of the elements. In fact, the presence of variations in the intraindividual elimination of MMAs with urine has been interpreted as first evidence of the existence of genetic polymorphisms in metabolic capacity (32, 33) , and several observations suggest that human metabolism of arsenic compounds varies among different individuals based on several factors, including genes involved in the biotransformation of arsenic (34, 35) . Genotypic variation may not only affect the metabolism of arsenic but also modify the individual susceptibility to arsenic-induced diseases, including cancer (36) . From the present study, it emerged that a significant increase in MN frequency was induced above the concentration of 2 lM. Sodium arsenate is known to induce a significant increase in CA and MN in mouse lymphoid cells (37) . Our results are in complete agreement with literature data on these inorganic arsenic salts since, in CHO cells, at least a one order of magnitude increase in the genotoxic effects of arsenite, compared to arsenate, has been reported (38) (39) (40) . Concerning the NDI (Tables 1 and 2 ) together with an increase on the BNMN, we observed a concentration-dependent decrease of the NDI, a clear indication of a cytotoxic effect induced by the treatment with both compounds.
Concerning the data on the organic compounds, like MMAs and DMAs, screened in this study, recent results on the cytotoxic capacity of these substances (15) indicate that the hypothesis of the methylation process as a detoxification pathway should be reconsidered. In this scenario, we have focussed our attention on the genotoxic properties of MMAs The trivalent methylated arsenicals are species that have the capability to interact with cytosolic proteins and that, under those circumstances, can produce some of the toxic effects. Moreover, these compounds have been considered potent cytotoxins in primary culture of rat hepatocytes and in this cell model, they have been shown to be significantly more cytotoxic compared with inorganic compounds, like arsenite and arsenate (41, 42) . By using a different endpoint, like the primary DNA damage, evaluated by the comet assay on human isolated lymphocytes, Mass et al. (43) being the most potent one tested. In summary, Kligerman et al. (21) have suggested that exposure to arsenic can lead to aneuploidy, with the trivalent methylated arsenicals being the more potent aneuploidy-inducing forms of arsenic. Here, we MMC, mitomycin C.
Genotoxicity induced by arsenic compounds
have provided direct evidence that MMAs III exerts its genotoxic effect acting mainly as an aneuploidogenic compound. We did not evaluate DMAs III in the present study; however, its genotoxic mechanism of action requires further clarification; in fact, Ochi et al. (44, 45) showed that dimethylarsinic acid causes mitotic delay, multipolar spindles and multipolar divisions, centrosome abnormality and CA in the Chinese hamster V79 mitotic cells. Both DMAs III and MMAs III were shown to interfere with tubulin polymerization in human lymphoblasts (21) . However, whereas MMAs III caused a significant concentration-related increase of the mitotic index, DMAs III effects on the mitotic index were quite variable and inconsistent, suggesting the need for further studies.
An increased cytotoxicity was observed for the three compounds MMAs III , MMAs V and DMAs V (Tables 3-5) ; however, the apparent higher cytotoxic effect of DMAs V compared with the other compounds could be due to the fact that we used much more higher concentrations than those used for the other compounds ($100-fold higher than those of MMAs III ). Ochi et al. (45, 46) observed that at equitoxic levels, the cytotoxic effect of DMAs III was about three orders of magnitude more potent than DMAs V on Chinese hamster V79 cells. They suggested that some of the cytotoxic effects of DMAs V could be attributed to the action of DMAs III , generated from DMAs V in an intracellular reducing environment. Their hypothesis was supported by evidence that the depletion of cellular GSH did not influence the cytotoxic effects of DMAs III , whereas it enhanced the cytotoxicity of DMAs V (45, 46) , suggesting that at least in their experimental system the interaction between GSH and reactive materials generated from DMAs V was critical for the cytotoxicity of DMAs V . Interestingly, DMAs V was the most potent mitotic inhibitor of the three pentavalent arsenicals examined by Kligerman et al. (21) on human lymphoblasts; however, it had no significant effect on tubulin polymerization. Based on this evidence, and considering that we used a concentration of DMAs V almost 100-fold higher than that of MMAs III , we can speculate that part of the cytotoxic effect of DMAs V observed in the present study could be due to the intracellular formation of a small amount of DMAs III , which has been observed to be much more powerful than DMAs V (45) . In our study, no toxic effect for TMAO V was observed suggesting, since this compound was found together with the TMAO III , as a metabolite in urine, that it could be a detoxification product.
Arsenic has been associated with a wide range of cancers, including cancer of lung, kidney, liver, skin and urinary bladder. Several mechanisms have been proposed to explain the carcinogenic properties of As, including arsenic-induced oxidative stress, perturbation of important intracellular pathways involved in cell proliferation, differentiation and apoptosis, DNA damage, followed by cell cycle arrest, a direct or indirect inhibition of DNA repair enzymes by arsenic, the perturbation of DNA methylation and induced genomic instability (36) .
Li and Broome (47) observed that arsenic was able to induce apoptosis in myeloid leukaemia cells by inhibiting tubulin polymerization, leading to a mitotic arrest, and suggested the possibility to design arsenic-based antimitotic agents to be used in cancer therapy. Recent data (21) provide evidence that some species of arsenicals, mainly DMAs III and MMAs III , interfere with tubulin polymerization. The present results provide further evidence that speciation plays an important role in determining the cytotoxic and genotoxic effects of As compounds. Moreover, we provide evidence that MMAs III shows an aneuploidogenic mechanism of genotoxicity, bringing into highlight the need for further studies to better understand the molecular mechanisms of action of arsenic compounds for a better comprehension of arsenic-induced carcinogenicity and for the development of arsenic-based cancer therapies.
